HOME › Top Market Reports › Cell Based Assays Market, By Product (Reagents, Assay Kits, Microplates, Cell Lines, Service), Application (Research, Drug Discovery, ADME Studies, Toxicology), End User (Biopharmaceutical Companies, Academic Institutions, CRO) – Global Forecast to 2022

Cell Based Assays Market, By Product (Reagents, Assay Kits, Microplates, Cell Lines, Service), Application (Research, Drug Discovery, ADME Studies, Toxicology), End User (Biopharmaceutical Companies, Academic Institutions, CRO) – Global Forecast to 2022

By: marketsandmarkets.com
Publishing Date: July 2017
Report Code: BT 2486

The cell-based assays market is expected to reach USD 19.92 Billion by 2022 from USD 13.34 Billion in 2017, at a CAGR of 8.4% during the forecast period from 2017 to 2022.

The objectives of this study are as follows:

To define, describe, and forecast the cell-based assays market by product, application, end user, and region
To provide detailed information regarding the major factors influencing growth of the market (drivers, restraints, and opportunities)
To analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall market
To analyze the opportunities in the market for stakeholders and provide details of a competitive landscape for market leaders
To forecast revenue of the market segments with respect to four main regional segments, namely, North America, Europe, Asia-Pacific, and the Rest of the World (RoW)
To profile key players and comprehensively analyze their market shares and core competencies in terms of market developments and growth strategies
To track and analyze competitive developments such as agreements, collaborations, and partnerships; acquisitions; and product launches in the global market

Research Methodology

Top-down and bottom-up approaches were used to estimate and validate the size of the market and estimate the size of various other dependent submarkets. The overall market size was used in the top-down approach to estimate the size of other individual markets (mentioned in the market segmentation—by product, application, end user, and region) through percentage splits from secondary and primary research. The bottom-up approach was also implemented (wherever applicable) for data extracted from secondary research to validate the market segment revenues obtained. Various secondary sources such as World Health Organization (WHO), International Federation for Cell Biology United Nations Department of Economic and Social Affairs (UN DESA), Organisation for Economic Co-operation and Development (OECD), Centers for Disease Control and Prevention (CDC), World Bank, Food and Drug Administration (FDA), American Association for Respiratory Care (AARC), Centers for Medicare & Medicaid Services (CMS), corporate filings such as annual reports, SEC filings, investor presentations, and financial statements have been used to identify and collect information useful for this extensive commercial study of the global market. Primary sources such as experts from related industries and suppliers have been interviewed to obtain and verify critical information as well as to assess prospects of the cell-based assays market. The breakdown of profiles of primaries is shown in the figure below:

Cell-based Assays Market

To know about the assumptions considered for the study, download the pdf brochure

The key players in the cell-based assays market include Merck KGaA (Germany), Becton, Dickinson and Company (U.S.), PerkinElmer Inc. (U.S.), Promega Corporation (U.S.), Danaher Corporation (U.S.), GE Healthcare (U.K), Thermo Fisher Scientific Inc. (U.S.), Cell Signaling Technology, Inc. (U.S.), BioTek Instruments, Inc. (U.S.), Lonza Group (U.S.), ProQinase GmbH (Germany), Charles River Laboratories, Inc (U.S.), Cisbio Bioassays (France), Miltenyi Biotec (Germany), Cell Biolabs, Inc. (U.S.), DiscoverX Corporation (U.S.), Marin Biologic Laboratories (U.S.), Biospherix, Ltd (U.S.), Essen BioScience Inc. (U.S.), Cell Biologics Inc. (U.S.), BioAgilytix Labs. (U.S.), Enzo Life Sciences, Inc. (Switzerland), Aurelia Bioscience Ltd. (U.K. ), Selexis SA (U.S.), and QGel SA (Switzerland).

Target Audience for this Report:

Cell-based assays manufacturers and vendors
Research associations related to drug discovery
Healthcare providers (hospitals, laboratories, medical schools, and outpatient clinics)
Various research and consulting firms
Distributors of cell-based assays
Academic and Research Institutes

Scope of the Report:

This report categorizes the market into the following segments:

Cell-based Assays Market, by Product

Consumables
- Reagents
- Assay Kits
  - Reporter Gene Assays
  - Cell Growth Assays
  - Second Messenger Assays
  - Cell Death Assays
  - Other Assays
- Microplates
- Cell Lines
  - Immortalized Cell Lines
  - Primary Cell Lines
  - Stem Cell Lines
- Probes and Labels
- Other Consumables
Instruments
Services
Software

Cell-based Assays Market, by Application

Drug discovery
Basic Research
ADME Studies
Predictive Toxicology
Other Applications

Cell-Based Assays Market, by End User

Pharmaceutical & Biotechnology Companies
Academic & Government Institutions
Contract Research Organizations
Other End Users

Cell-Based Assays Market, by Region

North America
- U.S.
- Canada
Europe
- France
- U.K.
- Germany
- Spain
- Italy
- Rest of Europe (RoE)
Asia-Pacific
- China
- Japan
- India
- Rest of Asia-Pacific (RoAPAC)
Rest of the World (RoW)

Customization Options:

Company Information: Detailed company profiles of five or more market players
Opportunities Assessment: A detailed report underlining the various growth opportunities presented in the market

Table of Contents

1 Introduction (Page No. - 15)
    1.1 Objectives of the Study
    1.2 Market Definition
           1.2.1 Markets Covered
           1.2.2 Years Considered for the Study
    1.3 Currency
    1.4 Limitations
    1.5 Stakeholders

2 Research Methodology (Page No. - 18)
    2.1 Secondary Data
           2.1.1 Key Data From Secondary Sources
    2.2 Primary Data
           2.2.1 Key Data From Primary Sources
    2.3 Market Size Estimation
           2.3.1 Bottom-Up Approach
           2.3.2 Top-Down Approach
    2.4 Market Breakdown and Data Triangulation
    2.5 Assumptions for the Study

3 Executive Summary (Page No. - 26)

4 Cell-Based Assays Market: Premium Insights (Page No. - 30)
    4.1 Cell-Based Assays: Market Overview
    4.2 Geographic Analysis: Global Market, By End User (2017)
    4.3 Geographical Snapshot of the Global Market
    4.4 Global Market, By Application, 2017 vs 2022

5 Market Overview (Page No. - 34)
    5.1 Introduction
    5.2 Market Dynamics
           5.2.1 Drivers
                    5.2.1.1 Rising Incidence of Chronic Diseases
                    5.2.1.2 Growing Availability of Funds for Research
                    5.2.1.3 Growing Preference for Cell-Based Assays
                    5.2.1.4 Increasing Drug Discovery Activity
           5.2.2 Restraint
                    5.2.2.1 High Cost of Instruments, Restrictions on Reagent Use
           5.2.3 Opportunity
                    5.2.3.1 Asian Countries

6 Cell-Based Assays Market, By Product and Service (Page No. - 40)
    6.1 Introduction
    6.2 Consumables
           6.2.1 Reagents
           6.2.2 Assay Kits
                    6.2.2.1 Reporter Gene Assays
                    6.2.2.2 Cell Growth Assays
                    6.2.2.3 Second Messenger Assays
                    6.2.2.4 Cell Death Assays
                    6.2.2.5 Other Assays
           6.2.3 Microplates
           6.2.4 Cell Lines
                    6.2.4.1 Immortalized Cell Lines
                    6.2.4.2 Primary Cell Lines
                    6.2.4.3 Stem Cell Lines
           6.2.5 Probes and Labels
           6.2.6 Other Consumables
    6.3 Instruments
    6.4 Services
    6.5 Software

7 Cell-Based Assays Market, By Application (Page No. - 60)
    7.1 Introduction
    7.2 Drug Discovery
    7.3 Basic Research
    7.4 Adme Studies
    7.5 Predictive Toxicology
    7.6 Other Applications

8 Cell-Based Assays Market, By End User (Page No. - 67)
    8.1 Introduction
    8.2 Pharmaceutical & Biotechnology Companies
    8.3 Academic & Government Institutions
    8.4 Contract Research Organizations
    8.5 Other End Users

9 Cell-Based Assays Market, By Region (Page No. - 74)
    9.1 Introduction
    9.2 North America
           9.2.1 U.S.
           9.2.2 Canada
    9.3 Europe
           9.3.1 Germany
           9.3.2 France
           9.3.3 U.K.
           9.3.4 Italy
           9.3.5 Spain
           9.3.6 RoE
    9.4 Asia
           9.4.1 China
           9.4.2 Japan
           9.4.3 India
           9.4.4 Rest of Asia
    9.5 Rest of the World

10 Competitive Landscape (Page No. - 120)
     10.1 Introduction
     10.2 Market Share Analysis
     10.3 Vendor Dive Overview
             10.3.1 Visionary Leaders
             10.3.2 Innovators
             10.3.3 Dynamic Differentiators
             10.3.4 Emerging Companies
     10.4 Competitive Benchmarking
             10.4.1 Business Strategies Adopted By Major Players in the Cell-Based Assays Market (25 Players)
             10.4.2 Analysis of Product Portfolio of Major Players in the Global Market (25 Players)

*Top 25 Companies Analysed for This Study are - Becton, Dickinson and Company. (U.S.), Cell Signaling Technology (U.S.), Danahar Corporation (U.S.), Cisbio Bioassays (France), Merck KGaA (Germany), Ge Healthcare (U.K), Discoverx Corporation (U.S.), Thermo Fisher Scientific Inc. (U.S.), Perkinelmer Inc. (U.S.), Promega Corporation (U.S.), Proqinase GmbH (Germany), Charles River Laboratories International, Inc. (U.S.), Marine Biological Laboratory (U.S.), Biospherix, Ltd. (U.S.), Essen Bioscience (U.S.), Miltenyi Biotec (Switzerland), Bioagilytix Labs. (U.S.), Enzo Life Sciences, Inc. (Switzerland), Lonza (Switzerland), Aurelia Bioscience Ltd. (U.K), Selexis Sa (U.S.), Life Technologies Corporation (U.S.), Cell Biolabs, Inc. (U.S.), Biotek Instruments, Inc. (U.S.), Qgel Sa (Switzerland)

11 Company Profiles (Page No. - 125)
(Overview, Products and Services, Financials, Strategy & Development)*
     11.1 Becton, Dickinson and Company
     11.2 Danaher Corporation
     11.3 Thermo Fisher Scientific Inc.
     11.4 General Electric Company
     11.5 Merck KGaA
     11.6 Perkinelmer, Inc.
     11.7 Charles River Laboratories, Inc.
     11.8 Lonza Group Ltd.
     11.9 Cell Signaling Technology, Inc.
     11.10 Promega Corporation
     11.11 Cisbio Bioassays
     11.12 Cell Biolabs, Inc.
     11.13 Discoverx Corporation

*Details on Overview, Products and Services, Financials, Strategy & Development Might Not Be Captured in Case of Unlisted Companies.

12 Appendix (Page No. - 157)
     12.1 Insights of Industry Experts
     12.2 Discussion Guide
     12.3 Knowledge Store: Marketsandmarkets’ Subscription Portal
     12.4 Introducing RT: Real-Time Market Intelligence
     12.5 Available Customizations
     12.6 Related Reports
     12.7 Author Details

List of Tables (86 Tables)

Table 1 Increase in Cancer Patient Population, By Cancer Type
Table 2 Cell-Based Assays Market, By Product & Service, 2015–2022 (USD Million)
Table 3 Market for Consumables, By Type, 2015–2022 (USD Million)
Table 4 Market for Consumables, By Region, 2015–2022 (USD Million)
Table 5 Market for Reagents, By Region, 2015–2022 (USD Million)
Table 6 Market for Assay Kits, By Type, 2015–2022 (USD Million)
Table 7 Cell-Based Assays Market for Assay Kits, By Region, 2015–2022 (USD Million)
Table 8 Market for Reporter Gene Assays, By Region, 2015–2022 (USD Million)
Table 9 Market for Cell Growth Assays, By Region, 2015–2022 (USD Million)
Table 10 Market for Second Messenger Assays, By Region, 2015–2022 (USD Million)
Table 11 Market for Cell Death Assays, By Region, 2015–2022 (USD Million)
Table 12 Other Cell-Based Assays Market, By Region, 2015–2022 (USD Million)
Table 13 Market for Microplates, By Region, 2015–2022 (USD Million)
Table 14 Market for Cell Lines, By Region, 2015–2022 (USD Million)
Table 15 Market for Cell Lines, By Type, 2015–2022 (USD Million)
Table 16 Market for Immortalized Cell Lines, By Region, 2015–2022 (USD Million)
Table 17 Cell-Based Assays Market for Primary Cell Lines, By Region, 2015–2022 (USD Million)
Table 18 Market for Stem Cell Lines, By Region, 2015–2022 (USD Million)
Table 19 Market for Probes and Labels, By Region, 2015–2022 (USD Million)
Table 20 Market for Other Consumables, By Region, 2015–2022 (USD Million)
Table 21 Market for Instruments, By Region, 2015–2022 (USD Million)
Table 22 Cell-Based Assays Market for Services, By Region, 2015–2022 (USD Million)
Table 23 Market for Software, By Region, 2015–2022 (USD Million)
Table 24 Market, By Application, 2015–2022 (USD Million)
Table 25 Market for Drug Discovery, By Region, 2015–2022 (USD Million)
Table 26 Market for Basic Research, By Region, 2015–2022 (USD Million)
Table 27 Cell-Based Assays Market for Adme Studies, By Region, 2015–2022 (USD Million)
Table 28 Market for Predictive Toxicology, By Region, 2015–2022 (USD Million)
Table 29 Other Cell-Based Assay Applications Market, By Region, 2015–2022 (USD Million)
Table 30 Market Size, By End User, 2015–2022 (USD Million)
Table 31 Market Size for Pharmaceutical & Biotechnology Companies, By Region, 2015–2022 (USD Million)
Table 32 Market Size for Academic & Government Institutions, By Region, 2015–2022 (USD Million)
Table 33 Market Size for Contract Research Organizations, By Region, 2015–2022 (USD Million)
Table 34 Market Size for Other End Users, By Region, 2015–2022 (USD Million)
Table 35 Market, By Region, 2015–2022 (USD Million)
Table 36 North America: Cell-Based Assays Market, By Country, 2015–2022 (USD Million)
Table 37 North America: Market Size, By Product & Service, 2015–2022 (USD Million)
Table 38 North America: Market, By Application, 2015–2022 (USD Million)
Table 39 North America: Market, By End User, 2015–2022 (USD Million)
Table 40 U.S.: Cell-Based Assays Market Size, By Product & Service, 2015–2022 (USD Million)
Table 41 U.S.: Market, By Application, 2015–2022 (USD Million)
Table 42 U.S.: Market, By End User, 2015–2022 (USD Million)
Table 43 Canada: Cell-Based Assays Market Size, By Product & Service, 2015–2022 (USD Million)
Table 44 Canada: Market, By Application, 2015–2022 (USD Million)
Table 45 Canada: Market, By End User, 2015–2022 (USD Million)
Table 46 Europe: Cell-Based Assays Market, By Country, 2015–2022 (USD Million)
Table 47 Europe: Market Size, By Product & Service, 2015–2022 (USD Million)
Table 48 Europe: Market, By Application, 2015–2022 (USD Million)
Table 49 Europe: Market, By End User, 2015–2022 (USD Million)
Table 50 Germany: Cell-Based Assays Market Size, By Product & Service, 2015–2022 (USD Million)
Table 51 Germany: Market, By Application, 2015–2022 (USD Million)
Table 52 Germany: Market, By End User, 2015–2022 (USD Million)
Table 53 France: Cell-Based Assays Market Size, By Product & Service, 2015–2022 (USD Million)
Table 54 France: Market, By Application, 2015–2022 (USD Million)
Table 55 France: Market, By End User, 2015–2022 (USD Million)
Table 56 U.K.: Cell-Based Assays Market Size, By Product & Service, 2015–2022 (USD Million)
Table 57 U.K.: Market, By Application, 2015–2022 (USD Million)
Table 58 U.K.: Market, By End User, 2015–2022 (USD Million)
Table 59 Italy: Cell-Based Assays Market Size, By Product & Service, 2015–2022 (USD Million)
Table 60 Italy: Market, By Application, 2015–2022 (USD Million)
Table 61 Italy: Market, By End User, 2015–2022 (USD Million)
Table 62 Spain: Cell-Based Assays Market Size, By Product & Service, 2015–2022 (USD Million)
Table 63 Spain: Market, By Application, 2015–2022 (USD Million)
Table 64 Spain: Market, By End User, 2015–2022 (USD Million)
Table 65 RoE: Cell-Based Assays Market Size, By Product & Service, 2015–2022 (USD Million)
Table 66 RoE: Market, By Application, 2015–2022 (USD Million)
Table 67 RoE: Market, By End User, 2015–2022 (USD Million)
Table 68 Asia: Cell-Based Assays Market, By Country, 2015–2022 (USD Million)
Table 69 Asia: Market Size, By Product & Service, 2015–2022 (USD Million)
Table 70 Asia: Market, By Application, 2015–2022 (USD Million)
Table 71 Asia: Market, By End User, 2015–2022 (USD Million)
Table 72 China: Cell-Based Assays Market Size, By Product & Service, 2015–2022 (USD Million)
Table 73 China: Market, By Application, 2015–2022 (USD Million)
Table 74 China: Market, By End User, 2015–2022 (USD Million)
Table 75 Japan: Cell-Based Assays Market Size, By Product & Service, 2015–2022 (USD Million)
Table 76 Japan: Market, By Application, 2015–2022 (USD Million)
Table 77 Japan: Market, By End User, 2015–2022 (USD Million)
Table 78 India: Cell-Based Assays Market Size, By Product & Service, 2015–2022 (USD Million)
Table 79 India: Market, By Application, 2015–2022 (USD Million)
Table 80 India: Market, By End User, 2015–2022 (USD Million)
Table 81 RoA: Cell-Based Assays Market Size, By Product & Service, 2015–2022 (USD Million)
Table 82 RoA: Market, By Application, 2015–2022 (USD Million)
Table 83 RoA: Market, By End User, 2015–2022 (USD Million)
Table 84 RoW: Cell-Based Assays Market Size, By Product & Service, 2015–2022 (USD Million)
Table 85 RoW: Market, By Application, 2015–2022 (USD Million)
Table 86 RoW: Market, By End User, 2015–2022 (USD Million)

List of Figures (48 Figures)

Figure 1 Global Cell-Based Assays Market
Figure 2 Research Design
Figure 3 Breakdown of Primary Interviews: By Company Type, Designation, and Region
Figure 4 Global Market: Bottom-Up Approach
Figure 5 Global Market: Top-Down Approach
Figure 6 Data Triangulation Methodology
Figure 7 Global Market, By Product & Service, 2017 vs 2022 (USD Billion)
Figure 8 Global Market, By Application, 2017 vs 2022 (USD Billion)
Figure 9 Global Market, By End User, 2017 vs 2022 (USD Billion)
Figure 10 Geographic Snapshot of the Global Market
Figure 11 Global Cell-Based Assays Market to Witness Moderate Growth During the Forecast Period
Figure 12 Pharmaceutical and Biotechnological Companies are Expected to Account for the Largest Share of the Global Market in 2017
Figure 13 Asia to Register the Highest Growth During the Forecast Period
Figure 14 Drug Discovery Segment Will Continue to Dominate the Global Market in 2022
Figure 15 Global Market: Drivers, Restraint, and Opportunitie
Figure 16 Consumables to Dominate the Market During 2017–2022
Figure 17 Drug Discovery Will Continue to Dominate the Global Market During the Forecast Period
Figure 18 Pharmaceutical & Biotechnology Companies to Dominate the Global Market During the Forecast Period
Figure 19 Asian Cell-Based Assays Market to Grow at the Highest Rate During the Forecast Period
Figure 20 Asian Market to Register the Higher CAGR During Forecast Period
Figure 21 North America: Market Snapshot
Figure 22 Pharmaceutical & Biotechnology Companies to Account for the Largest Share of the End-User Market in North America
Figure 23 Consumables, the Largest Segment in the U.S. Market, By Product & Service, in 2017
Figure 24 Drug Discovery Application Segment to Dominate the Canadian Market in 2017
Figure 25 Contract Research Organizations, the Fastest-Growing End-User Segment in Europe
Figure 26 Consumables Estimated to Be the Largest Product & Service Segment in the German Assays Market in 2017
Figure 27 Drug Discovery to Dominate the French Cell-Based Assays Market, By Application, in 2017
Figure 28 Consumables, the Largest Product & Service Segment in the U.K. Market in 2017
Figure 29 Pharmaceutical & Biotechnology Companies to Be the Largest End-User Segment in the Italian Market, 2017
Figure 30 Drug Discovery, the Largest Application Segment in the Spanish Market in 2017
Figure 31 RoE Market, By End User: Pharmaceutical & Biotechnology Companies Estimated to Hold Largest Share in 2017
Figure 32 Asia: Market Snapshot
Figure 33 Consumables to Account for the Largest Product Segment of the Market in Asia in 2017
Figure 34 Pharmaceutical & Biotechnology Companies to Account for the Largest End-User Segment of the Market in China in 2017
Figure 35 Consumables to Account for the Largest Share of the Cell-Based Assays Market, By Product & Service, in Japan, 2017
Figure 36 Drug Discovery to Account for the Largest Application of the Global Market in India in 2017
Figure 37 Pharmaceutical & Biotechnology Companies to Account for the Largest End-User of the Market in RoA in 2017
Figure 38 Consumables to Account for the Largest Share of the Market in RoW in 2017
Figure 39 Global Cell-Based Assays Market Share Analysis, By Key Player, 2016
Figure 40 Dive Chart
Figure 41 Becton, Dickinson and Company: Company Snapshot (2016)
Figure 42 Danaher Corporation: Company Snapshot (2016)
Figure 43 Thermo Fisher Scientific Inc.: Company Snapshot (2016)
Figure 44 General Electric Company: Company Snapshot (2016)
Figure 45 Merck KGaA: Company Snapshot (2016)
Figure 46 Perkinelmer, Inc.: Company Snapshot (2017)
Figure 47 Charles River Laboratories, Inc.: Company Snapshot (2016)
Figure 48 Lonza Group Ltd.: Company Snapshot (2016)

The global cell-based assays market is expected to reach USD 19.92 Billion by 2022 from USD 13.34 Billion in 2017, at a CAGR of 8.4%. A number of factors, such as growing funding and investments in R&D, the increasing prevalence of chronic disorders, increase in drug discovery activities, and the advantages of cell-based assays over alternative technologies are expected to drive the growth of this market.

The global market is segmented by product, application, end user, and region. By product, the global market is segmented into consumables, instruments, service and software. The consumables segment is expected to lead the global cell-based assays market in 2017. The rising prevalence of chronic disorders and technical innovations in the field are key growth factors of this subsegment.

By application, the market is classified into drug discovery, basic research, ADME studies, predictive toxicology and other applications. The drug manufacturers are mostly confined to using cell-based assays during the drug development process, this drives the drug discovery applications segment and helps the segment hold the largest share of the cell-based assays market in 2017.

On the basis of end users, the equipment market is segmented into pharmaceutical and biotechnology companies, academic and government institutions, contract research organizations, and other end users. In 2017, the pharmaceutical and biotechnology companies segment accounted for the greatest share and is also projected to grow at the highest rate during the forecast period. Technological improvements and the growing usage of cell-based assays, especially in developed countries of North America and Europe are major factors fueling the growth in this end-user segment.

Cell-based Assays Market

The global cell-based assays market is dominated by North America, followed by Europe. North America will continue to dominate the global market in the forecast period. Asia-Pacific, however, is expected to witness the highest CAGR during the forecast period. The growth in this market centered at China, Japan, and India. Increasing investment in healthcare, rise in healthcare expenditure, growth in disposable incomes, and an increase in healthcare insurance coverage are some factors propelling market growth in the APAC region.

The availability of low-cost substitutes by local manufacturers, rigorous regulatory guidelines causing delays in product approvals, are expected to restrain the market growth to a certain extent.

Major industry players launched innovative products to improve and maintain their market shares. Players also expanded across geographies via partnerships and acquisitions. Becton, Dickinson and Company (U.S.), Cisbio Bioassays (France), PerkinElmer, Inc. (U.S.), and Danaher Corporation (U.S.) have been identified as the key players in this market. These companies have a broad product portfolio with comprehensive features and have also launched innovative products. Further, these leaders have products for all end users in this segment, a strong geographical presence, and more importantly, focus on continuous product innovations.

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

Custom Market Research Services